IRIS
ALTAVILLA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.147
EU - Europa 7.901
AS - Asia 4.190
SA - Sud America 1.622
AF - Africa 111
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.024
RU - Federazione Russa 2.436
SG - Singapore 1.878
BR - Brasile 1.467
IE - Irlanda 1.312
SE - Svezia 1.239
CN - Cina 1.175
IT - Italia 789
HK - Hong Kong 521
DE - Germania 490
UA - Ucraina 479
GB - Regno Unito 306
FI - Finlandia 263
PL - Polonia 193
VN - Vietnam 176
FR - Francia 120
IN - India 94
BE - Belgio 64
TR - Turchia 54
AR - Argentina 47
CA - Canada 45
MX - Messico 43
BD - Bangladesh 41
ZA - Sudafrica 35
AT - Austria 32
EC - Ecuador 32
ID - Indonesia 32
IQ - Iraq 31
NL - Olanda 31
ES - Italia 30
UZ - Uzbekistan 24
CZ - Repubblica Ceca 23
MA - Marocco 22
CO - Colombia 21
JP - Giappone 20
VE - Venezuela 17
IR - Iran 15
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 13
AL - Albania 11
LT - Lituania 11
BO - Bolivia 10
CH - Svizzera 10
CI - Costa d'Avorio 10
KE - Kenya 10
PK - Pakistan 10
TN - Tunisia 10
JO - Giordania 9
KG - Kirghizistan 9
AU - Australia 8
GR - Grecia 8
IL - Israele 8
KZ - Kazakistan 8
PY - Paraguay 8
CL - Cile 7
DO - Repubblica Dominicana 7
EG - Egitto 7
JM - Giamaica 7
OM - Oman 7
PE - Perù 6
RS - Serbia 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
GE - Georgia 5
NI - Nicaragua 5
NO - Norvegia 5
NP - Nepal 5
PA - Panama 5
RO - Romania 5
SA - Arabia Saudita 5
UY - Uruguay 5
AO - Angola 4
BY - Bielorussia 4
HN - Honduras 4
KW - Kuwait 4
LV - Lettonia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
HR - Croazia 3
HU - Ungheria 3
KR - Corea 3
LB - Libano 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BW - Botswana 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GA - Gabon 2
KH - Cambogia 2
MY - Malesia 2
PT - Portogallo 2
TW - Taiwan 2
Totale 21.971
Salva come PNG Salva come JPEG
Città #
Dublin 1.312
Moscow 1.209
Chandler 1.006
Jacksonville 941
Singapore 926
Dallas 918
Ashburn 910
Nyköping 691
Hong Kong 516
Beijing 478
Dearborn 251
Ann Arbor 244
Los Angeles 243
Princeton 220
Medford 201
Cambridge 199
Warsaw 185
New York 162
Messina 160
The Dalles 154
Des Moines 152
Boardman 129
Munich 121
São Paulo 113
Lancaster 110
Buffalo 90
Jinan 78
Tianjin 71
Woodbridge 67
Brussels 61
Ho Chi Minh City 58
Shenyang 52
Redondo Beach 51
Rio de Janeiro 50
Turku 50
Wilmington 49
San Mateo 45
Houston 38
Belo Horizonte 35
Nanjing 35
Hanoi 33
Frankfurt am Main 32
Santa Clara 30
Hyderabad 29
Rome 29
Catania 28
Hebei 27
Zhengzhou 27
Brasília 26
Brooklyn 26
Pune 26
Vienna 26
San Francisco 24
Council Bluffs 23
Jakarta 23
Seattle 23
Tashkent 23
Chicago 22
London 22
Milan 22
Montreal 22
Curitiba 21
Washington 21
Haikou 20
Nanchang 20
Nuremberg 20
Porto Alegre 20
Tokyo 20
Atlanta 19
Denver 19
Düsseldorf 19
Helsinki 19
Johannesburg 18
Ningbo 18
Dong Ket 17
Norwalk 17
Stockholm 17
Boston 16
Ankara 15
Bremen 15
Campinas 15
Guangzhou 15
Istanbul 15
Phoenix 15
Ribeirão Preto 15
Scarsdale 15
Baghdad 14
Brno 14
Hangzhou 14
Orem 14
Salvador 14
Sorocaba 14
Taizhou 14
Changsha 13
Jiaxing 13
Poplar 13
Redwood City 13
Baku 12
Guayaquil 12
Recife 12
Totale 13.551
Salva come PNG Salva come JPEG
Nome #
PARAGANGLIOMA MALIGNO DEL CORPO CAROTIDEO.Rilievi Clinici, Morfologici, Istochimici E Ultrastrutturali Su Un Caso. 408
Su di un caso di pseudomyxoma peritonei con diffusione spontanea alla pleura. 179
Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. 179
Annual increase in the frequency of papillary thyroid carcinoma as diagnosed by fine-needle aspiration at a cytology unit in Sicily. 177
Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy 177
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 176
Bone and lymph node metastases from occult mammary carcinoma: a case report of carcinoma of unknown primary (CUP) Syndrome 174
Mechanical dispersion and cardiotoxicity in patients who underwent chemotherapy for breast cancer: an echocardiographic study 174
Analysis of multilayer strain and myocardial work in patients undergoing chemotherapy treatment: a 12 months follow-up 169
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation 168
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 166
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 164
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 154
Liver dysfunction in hcv infected patients with CD20-Positive B-Cell Lymphoma undergoing rituximab combination chemotherapy 153
[Serum levels of copper and zinc in patients with lung cancer] 153
Should the Use of Surveillance Imaging in Diffuse Large B-Cell Lymphoma Be Discontinued? 151
Myocardial damage pattern in women with breast cancer who underwent chemotherapy: strain polar maps analysis 151
An acute-leukaemia-like picture due to breast carcinoma cells. 149
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy 149
A study of endometrial adenocarcinoma treated with tamoxifen by scanning and transmission electron microscopy. 148
EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients. 148
Applications of genomics in NSCLC 147
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 147
Liquid biopsy for lung cancer early detection 145
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 144
Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer 144
Left atrial function in patients undergoing chemotherapy: additional value of 2D longitudinal strain 144
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 144
A randomized factorial trial of sequential doxrubicina and CMF vs CMF and chemoterapy alone vs chemoterapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer 143
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 142
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 142
Alectinib: A selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer 142
[(186)Re]HEDP in the palliation of painful bone metastases from cancers otherthan prostate and breast. 141
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 140
Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome. 140
Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck 139
Early assessment of chemotherapy-related cardiovascular toxicity in patients with breast cancer 139
The treatment of peritoneal carcinomatosis in elderly patients. 138
Endocrine toxicity of immune checkpoint inhibitors (anti-PD-1/PD-L1) in advanced cancer 138
A novel HPLC method for the determination of mitoxantrone in pharmaceutical formulations. 137
Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. 137
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma 136
A PHASE III RANDOMIZED TRIAL COMPARING THREE PLATINUM-BASED DOUBLETS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): IMPACT OF PS=2 VS 0 OR 1 AND AGE ³70 VS <70 ON CHEMOTHERAPY OUTCOME 135
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 134
Antiblastic treatment of advanced cervical carcinoma and its recurrences: assessment of four different polychemotherapies used for a decade. 133
Analytical profile and release of lonidamine from pharmaceutical formulation 131
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 130
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. 130
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST 129
Razionale e tecniche della chirurgia citoriduttiva e della chemioipertermia peritoneale. 129
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer. 129
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 129
A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin 128
Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder: Phase II study 128
Studio anatomo-clinico di due casi di sarcoma sinoviale monofasico del ginocchio 127
90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST 125
Psycho-Neuro-Endocrine-Immune System (PNEI) Involvement as Prognostic Marker in Breast Cancer Patients at 10 Years of Follow Up 124
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 123
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 123
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 122
Trattamento palliativo dei tumori del retto-sigma mediante elettrocoagulazione endoscopica.” 121
Thyroid function, autoimmunity and nodules in hematological malignancies 121
Unusual relapse of hepatocellular carcinoma 121
Sternal metastasis as initial presentation of a unknown rectal cancer 120
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation 120
La farmacogenomica nei tumori del polmone 120
Targeted drugs in small-cell lung cancer 120
Clodronate and radiotherapy for the treatment of osteolysis caused by metastasis of breast carcinoma and non-small cell lung carcinoma. A retrospective study 117
Peritoneal carcinomatosis of colorectal origin. 117
A PHASE II STUDY (21 day regimen) OF GEMCITABINE (Gem) AND CISPLATIN ( Cis) IN ADVANCED/METASTATIC TRANSITIONAL CELL CARCINOMA (TTC) OF BLADDER 116
Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases 116
Retrospective analiysis of P-STAT6 expression as predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate 114
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis? 114
Gemcitabine combined with Oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma 114
Transpersonal Therapy Combined with Best Supportive Care In Hospice Improve Patient’s Quality of Life and Quality Of Death 113
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery 113
SUBCUTANEOUS LOW-DOSE ALEMTUZUMAB AS FIRST LINE THERAPY FOR ELDERLY CLL PATIENTS WITH DELETION OF 17p 112
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 112
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 110
Treatment of advanced and/or metastatic epidermoid carcinoma of the head and neck: an effective combination chemotherapy with bleomycin, methotrexate and ftorafur. 108
Behavior of serum sialic acid levels at various stages of neoplastic disease 108
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 108
First Line Chemotherapy with Oral Vinorelbine (oV) in Elderly Hormone-Refractory Prostate Cancer (HRPC) Patients (pts 107
Relapsed or refractory extranodal DLBCL treated with lenalidomide: A single center study 107
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study 106
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA 106
Phase II study paclitaxel (PTX) and cisplatin (Cis) in advanced and recurrent head&neck cancer 105
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. 105
INFLUENCE OF CYP2C9 POLYMORPHISM IN LUNG CANCER SUSCEPTIBILITY 104
ZD 1839 IRESSA IN HEAVELY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) ASSESSMENT OF TOLERABILITY AND THE CLINICAL BENEFIT 104
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer. 104
Use of bisphosphonates in oncology 104
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy 104
The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB) 103
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 103
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study. 102
Serum levels of copper and zinc in patients with lung cancer 101
Temozolomide-induced shrinkage of a pituitary carcinoma. 101
PIK3CA mutations in breast cancer: a potential marker 100
ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER 100
Totale 13.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021784 0 0 0 0 0 170 48 148 64 169 118 67
2021/20221.555 10 224 45 40 59 20 84 61 31 244 269 468
2022/20233.927 312 372 174 289 306 401 57 236 1.613 22 96 49
2023/2024998 76 128 66 115 74 261 23 45 3 80 26 101
2024/20254.341 57 38 75 254 222 135 75 1.028 1.162 250 339 706
2025/20266.534 621 668 1.013 695 977 2.560 0 0 0 0 0 0
Totale 22.278